| Drug Name |
Strength |
Dosage Form/Route |
Company |
Marketing Status |
Approval year |
| BYETTA | 5 μg(0.25 MG/ML,1.2 ML/VIAL） | INJECTABLE; INJECTION | ASTRAZENECA AB | Prescription | 2009 |
| BYETTA | 5 μg(0.25 MG/ML,1.2 ML/VIAL） | INJECTABLE; INJECTION | ASTRAZENECA AB | Prescription | 2009 |
| BYETTA | 5 μg(0.25 MG/ML,1.2 ML/VIAL） | INJECTABLE; INJECTION | ASTRAZENECA AB | Prescription | 2009 |
| BYETTA | 5 μg(0.25 MG/ML,1.2 ML/VIAL） | INJECTABLE; INJECTION | ASTRAZENECA AB | Prescription | 2009 |
| BYETTA | 5 μg(0.25 MG/ML,1.2 ML/VIAL） | INJECTABLE; INJECTION | ASTRAZENECA AB | Prescription | 2009 |
| BYETTA | 5 μg(0.25 MG/ML,1.2 ML/VIAL） | INJECTABLE; INJECTION | ASTRAZENECA AB | Prescription | 2009 |
| BYETTA | 5 μg(0.25 MG/ML,1.2 ML/VIAL） | INJECTABLE; INJECTION | ASTRAZENECA AB | Prescription | 2009 |
| BYETTA | 5 μg(0.25 MG/ML,1.2 ML/VIAL） | INJECTABLE; INJECTION | ASTRAZENECA AB | Prescription | 2009 |
| BYETTA | 5 μg(0.25 MG/ML,1.2 ML/VIAL） | INJECTABLE; INJECTION | ASTRAZENECA AB | Prescription | 2009 |
| BYETTA | 5 μg(0.25 MG/ML,1.2 ML/VIAL） | INJECTABLE; INJECTION | ASTRAZENECA AB | Prescription | 2009 |
| BYETTA | 5 μg(0.25 MG/ML,1.2 ML/VIAL） | INJECTABLE; INJECTION | ASTRAZENECA AB | Prescription | 2009 |